Literature DB >> 17498506

The adipocyte as an active participant in energy balance and metabolism.

Michael K Badman1, Jeffrey S Flier.   

Abstract

Obesity is responsible for the mounting incidence of metabolic disease in adult and pediatric populations. Understanding of the pathogenesis and maintenance of the obese state has advanced rapidly over the past 10 years. Bodily energy reserves are managed actively by complex systems that regulate food intake, substrate partitioning, and energy expenditure. An underlying assumption that circulating factors released from storage organs were able to signal bodily energy reserves was confirmed with the discovery of the leptin system. This proof of concept has spurred on the discovery of a multitude of other adipocyte-generated factors. These circulating factors signal to the brain and other organs of metabolic importance, including adipose tissue, liver, muscle, and the immune system. Adipose-derived factors have numerous implications for the basic biology of obesity and provide prospective targets for the amelioration of obesity and its adverse metabolic consequences. In this review we detail the current understanding of leptin as a prototypical adipose tissue-derived hormone related to appetite and obesity. We also describe other important adipose-derived factors in relation to their metabolic effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498506     DOI: 10.1053/j.gastro.2007.03.058

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  91 in total

Review 1.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  The neuroendocrine basis of lactation-induced suppression of GnRH: role of kisspeptin and leptin.

Authors:  M Susan Smith; Cadence True; K L Grove
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

3.  Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.

Authors:  Chao-Ping Wang; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2007-08-10

4.  Gene expression profiling reveals a diverse array of pathways inhibited by nuclear receptor SHP during adipogenesis.

Authors:  Guisheng Song; Kyungtae Park; Li Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-11-03

Review 5.  Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

Authors:  Enzo Bonora; Giovanni Targher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-08       Impact factor: 46.802

6.  Myeloid cell-specific disruption of Period1 and Period2 exacerbates diet-induced inflammation and insulin resistance.

Authors:  Hang Xu; Honggui Li; Shih-Lung Woo; Sam-Moon Kim; Vikram R Shende; Nichole Neuendorff; Xin Guo; Ting Guo; Ting Qi; Ya Pei; Yan Zhao; Xiang Hu; Jiajia Zhao; Lili Chen; Lulu Chen; Jun-Yuan Ji; Robert C Alaniz; David J Earnest; Chaodong Wu
Journal:  J Biol Chem       Date:  2014-04-25       Impact factor: 5.157

7.  Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulation.

Authors:  Patrick Hindlet; André Bado; Peter Kamenicky; Claudine Deloménie; Fanchon Bourasset; Corinne Nazaret; Robert Farinotti; Marion Buyse
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

8.  P311 functions in an alternative pathway of lipid accumulation that is induced by retinoic acid.

Authors:  James K Leung; Sylvaine Cases; Thiennu H Vu
Journal:  J Cell Sci       Date:  2008-07-29       Impact factor: 5.285

9.  Adult consequences of post-weaning high fat feeding on the limbic-HPA axis of female rats.

Authors:  George Boukouvalas; Kyriaki Gerozissis; Efthimia Kitraki
Journal:  Cell Mol Neurobiol       Date:  2009-11-10       Impact factor: 5.046

Review 10.  Adipokines and the peripheral and neural control of energy balance.

Authors:  Rexford S Ahima; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2008-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.